Kumovis closes €3.6 million Series A funding round with PEEK medical 3D printing
Summary
Leveraging the investment, Kumovis plans to enter new markets, accelerate growth, and enable medical device manufacturers to utilize its high-performance polymer 3D printing technology. “From the very beginning of our business venture, we have set ourselves the goal to enable medtech companies and hospitals alike to process high-performance polymers, and consequently 3D print medical products of nearly any kind,” explains Stefan Leonhardt, co-CEO and co-founder of Kumovis. The company is the developer of the R1 3D printer, a system powered by fused layer manufacturing (FLM) technology, and geared towards use in the healthcare sector. Commercially released in late 2019, the R1’s key features include a temperature control and optional filter system, allowing users to create a “clean room” environment where foreign particles are prevented from entering the build chamber. By decentralizing production capacities using 3D printing, supply chains are shortened and, in the case for the medical sector, the time to patient is reduced.